Hedge Fund Fights Over Stem-Cell Company's Value in Cayman Court
A researcher applies supplement to stem cells in a lab in California, U.S. (Photographer: Noah Berger/Bloomberg)

Hedge Fund Fights Over Stem-Cell Company's Value in Cayman Court

Bookmark
(Bloomberg) -- A case brought by a U.S. hedge fund against China’s Global Cord Blood Corp. may set a precedent in the Cayman Islands for other minority shareholders who feel shortchanged by all-sha...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.